CSIMarket Company Name, Ticker, Suppliers, else..
 

Healthcare Sector

Biotechnology & Pharmaceuticals Industry Growth  


 

Growth Rates by Company within Biotechnology & Pharmaceuticals Industry

New: More Biotechnology & Pharmaceuticals Industrys' historic revenue growth >>

 Revenue Growth Net Income Growth
Company Quarter Y / Y Sequential Y / Y Sequential
Acumen Pharmaceuticals Inc 4Q 2024 - - - -
Atlantic Coastal Acquisition Corp Ii 3Q 2024 - - - -
Aceragen Inc 1Q 2023 - down -48.68 % - -
Achilles Therapeutics Plc 4Q 2023 - - - -
Arcellx Inc 4Q 2024 down-75.83 % down -41.35 % - -
Acorda Therapeutics Inc 1Q 2024 down-35.53 % down -26.79 % - -
Adaptimmune Therapeutics Plc 4Q 2024 - - - -
Adma Biologics Inc 4Q 2024 up 157.06 % up 60.95 % up 5562.25 % up 353 %
Adaptive Biotechnologies Corporation 4Q 2024 up 3.66 % up 2.21 % - -
Adverum Biotechnologies Inc 4Q 2024 - - - -
Agenus Inc 4Q 2024 down-67.98 % up 6.87 % - -
Aim Immunotech Inc 4Q 2024 down-30.77 % up 28.57 % - -
Avalon Globocare Corp 4Q 2024 up 4.37 % up 0.18 % - -
Alector Inc 4Q 2024 up 257.08 % up 253.54 % - -
Aligos Therapeutics Inc 4Q 2024 down-76.54 % down -50.43 % - -
Allogene Therapeutics inc 4Q 2024 - - - -
Alvotech 4Q 2023 - - - -
Allovir Inc 4Q 2024 - - - -
Ambrx Biopharma Inc 3Q 2023 down-99.29 % down -95.28 % - -
Amgen Inc 4Q 2024 up 10.86 % up 6.86 % down -18.25 % down -77.84 %
Apogee Therapeutics Inc 4Q 2024 - - - -
Aptose Biosciences Inc 4Q 2024 - - - -
Armata Pharmaceuticals Inc 4Q 2024 down-19.18 % down -58.46 % - -
Artiva Biotherapeutics Inc 4Q 2024 - - - -
Athira Pharma Inc 4Q 2024 - - - -
Atara Biotherapeutics Inc 4Q 2024 up 928.14 % up 17.2 % - -
Atyr Pharma Inc 4Q 2024 - - - -
Aura Biosciences Inc 4Q 2024 - - - -
Autolus Therapeutics Plc 4Q 2024 - - - -
Anavex Life Sciences Corp 4Q 2024 - - - -
Axcella Health Inc 2Q 2023 - - - -
Bioatla Inc 4Q 2024 - - - -
Biocardia Inc 4Q 2024 - - - -
Brainstorm Cell Therapeutics Inc 4Q 2024 - - - -
Biocryst Pharmaceuticals Inc 4Q 2024 up 40.83 % up 12.34 % - -
Black Diamond Therapeutics Inc 4Q 2024 - - - -
Beam Therapeutics Inc 4Q 2024 down-90.49 % up 110.72 % - -
Biogen Inc 4Q 2024 up 2.87 % down -0.45 % up 7.15 % down -31.35 %
Bluebird Bio Inc 4Q 2024 up 391.72 % up 262.99 % up 12.93 % up 240418.97 %
Biontech Se 4Q 2023 - - down -90.14 % down -90.14 %
Zeo Scientifix Inc 4Q 2024 down-5.55 % down -12.38 % - -
Cabaletta Bio Inc 4Q 2024 - - - -
Candel Therapeutics Inc 4Q 2024 - - - -
C4 Therapeutics Inc 4Q 2024 up 58.75 % down -66.3 % - -
Cidara Therapeutics Inc 4Q 2024 - - - -
Creative Medical Technology Holdings Inc 4Q 2024 flat 0 % - - -
Cullinan Therapeutics Inc 4Q 2024 - - - -
Compugen Ltd 4Q 2024 up 271.52 % up 271.52 % - -
Cg Oncology Inc 4Q 2024 - up 960.47 % - -
Cognition Therapeutics inc 4Q 2024 - - - -
Channel Therapeutics Corporation 4Q 2024 - - - -
Coherus Biosciences inc 4Q 2024 down-40.84 % down -23.5 % - -
Calidi Biotherapeutics Inc 4Q 2024 - - - -
Compass Therapeutics Inc 4Q 2024 - - - -
Coeptis Therapeutics Holdings Inc 4Q 2024 - - - -
Caribou Biosciences Inc 4Q 2024 down-41.62 % up 2.62 % - -
Cardiff Oncology Inc 3Q 2024 down-85.79 % up 1.23 % - -
Cardiol Therapeutics inc 4Q 2023 - - - -
Cargo Therapeutics Inc 4Q 2024 - - - -
Curis Inc 4Q 2024 up 24.07 % up 14.12 % - -
Crispr Therapeutics Ag 4Q 2024 down-82.26 % up 5828.74 % - -
Champions Oncology Inc 4Q 2024 up 41.77 % up 26.32 % - up 517.45 %
Cel sci Corporation 4Q 2024 - - - -
Cyclo Therapeutics Inc 3Q 2024 down-52.82 % up 89.9 % - -
Dbv Technologies S a 3Q 2024 down-54.81 % down -7.67 % - -
Ginkgo Bioworks Holdings Inc 4Q 2024 down-20.9 % down -50.76 % - -
Denali Therapeutics Inc 4Q 2024 - - - -
Precision Biosciences Inc 4Q 2024 down-90.93 % up 10.76 % - -
Dyadic International Inc 4Q 2024 up 19.06 % down -58.24 % - -
Editas Medicine Inc 4Q 2024 down-49.03 % up 50072.13 % - -
Eiger Biopharmaceuticals Inc 4Q 2023 up 41.06 % up 18.51 % - -
Elevation Oncology inc 4Q 2024 - - - -
Eloxx Pharmaceuticals Inc 3Q 2023 - - - -
Elutia inc 4Q 2024 down-3.15 % up 10.16 % - -
Engene Holdings Inc 4Q 2024 - - up 129.82 % up 60.9 %
Entera Bio Ltd 4Q 2024 - up 230.95 % down -10.72 % down -29.69 %
Enzon Pharmaceuticals inc 4Q 2024 down-14.55 % down -16.51 % - -
Tradeup Acquisition Corp 1Q 2024 - - - -
Evaxion Biotech A 4Q 2023 - - - -
Exelixis Inc 4Q 2024 up 18.16 % up 5.04 % up 72.17 % up 19.03 %
Exozymes Inc 4Q 2024 - - - -
Fate Therapeutics Inc 4Q 2024 up 10.98 % down -39.49 % - -
4d Molecular Therapeutics Inc 4Q 2024 - down -66.67 % - -
Fennec Pharmaceuticals inc 4Q 2024 - - - -
Finch Therapeutics Group Inc 2Q 2024 - - - -
Fresh Tracks Therapeutics Inc 4Q 2023 - - - -
Fusion Pharmaceuticals Inc 1Q 2024 - - - -
Agentix Corp 4Q 2024 - - - -
Gilead Sciences Inc 4Q 2024 up 6.4 % up 0.32 % up 25.83 % up 42.3 %
Monte Rosa Therapeutics Inc 4Q 2024 - up 558.06 % - -
Gamida Cell Ltd 1Q 2024 - up 32.24 % down -12.5 % up 1213.1 %
Genfit S a 4Q 2023 up 43.7 % up 43.7 % - -
Genenta Science S p a 4Q 2024 - - - -
Green Planet Bioengineering Co Ltd 4Q 2024 - - - -
Greenlight Biosciences Holdings Pbc 1Q 2023 up 1386.38 % up 26.36 % - -
Gritstone Bio Inc 2Q 2024 down-52.89 % down -47.13 % - -
Halozyme Therapeutics Inc 4Q 2024 up 29.55 % up 2.73 % up 60.46 % flat 0 %
Hillevax Inc 4Q 2024 - - - -
Humacyte Inc 4Q 2024 - up 205.25 % - -
Immunitybio inc 4Q 2024 up 5333.09 % up 23.68 % - -
Icosavax Inc 3Q 2023 - - - -
Ikena Oncology Inc 4Q 2024 - - - -
Inhibikase Therapeutics Inc 4Q 2024 - - - -
Immunocore Holdings Plc 4Q 2024 - up 4.74 % - -
Immunovant Inc 4Q 2024 - - - -
In8bio Inc 4Q 2024 - - - -
Inhibrx Biosciences Inc 4Q 2024 down-93.88 % - - -
Mink Therapeutics Inc 4Q 2024 - - - -
Inmune Bio Inc 4Q 2024 - - - -
Intensity Therapeutics Inc 3Q 2024 - - - -
Iovance Biotherapeutics Inc 4Q 2024 up 15189.21 % up 25.85 % - -
Innate Pharma Sa 4Q 2023 up 6.88 % up 6.88 % - -
Century Therapeutics inc 4Q 2024 up 1456.72 % up 427.43 % - -
Iteos Therapeutics Inc 4Q 2024 - - - -
Invivyd Inc 4Q 2024 - up 48.6 % - -
Jasper Therapeutics Inc 4Q 2024 - - - -
Kodiak Sciences Inc 4Q 2024 - - - -
Kiromic Biopharma Inc 4Q 2024 - - - -
Krystal Biotech Inc 4Q 2024 up 116.26 % up 8.71 % up 423.23 % up 67.33 %
Kymera Therapeutics Inc 4Q 2024 down-84.56 % up 97.65 % - -
Kyverna Therapeutics Inc 4Q 2024 - - - -
Ladrx Corporation 4Q 2024 - - - -
Lineage Cell Therapeutics Inc 4Q 2024 up 37.36 % down -24.11 % - -
Lenz Therapeutics Inc 4Q 2024 - - - -
Lexeo Therapeutics Inc 4Q 2024 - - - -
Mesoblast Ltd 2Q 2024 down-21.32 % down -21.32 % - -
Meiragtx Holdings Plc 4Q 2024 up 948.53 % up 96.06 % - -
Metagenomi Inc 4Q 2024 - down -16.5 % - -
Miromatrix Medical inc 3Q 2023 down-9.83 % up 31.22 % - -
Molecular Partners Ag 4Q 2023 down-96.29 % down -96.29 % - -
Moderna Inc 4Q 2024 down-65.64 % down -48.12 % - -
Mymetics Corporation 3Q 2023 down-73.85 % down -81.62 % - -
Neurocrine Biosciences Inc 4Q 2024 up 21.84 % up 0.9 % down -30.2 % down -20.57 %
Nkgen Biotech Inc 3Q 2024 - - - -
Neumora Therapeutics Inc 4Q 2024 - - - -
Nanostring Technologies Inc 3Q 2023 up 62.79 % up 8.9 % - -
Novavax inc 4Q 2024 down-69.69 % up 4.5 % - -
Ocugen Inc 4Q 2024 down-87.34 % down -32.75 % - -
Omega Therapeutics Inc 3Q 2024 up 214.32 % up 22.4 % - -
Organovo Holdings Inc 4Q 2024 up 380 % down -20 % - -
Opthea Limited 2Q 2024 up 15 % up 15 % - -
Orchard Therapeutics Plc 3Q 2023 up 9.09 % down -13.84 % - -
Outlook Therapeutics Inc 4Q 2024 - - - up 205.34 %
Palisade Bio Inc 4Q 2024 - - - -
Passage Bio inc 4Q 2024 - - - -
Phoenix Biotech Acquisition Corp 4Q 2024 - - - -
Point Of Care Nano technology Inc 1Q 2024 - - - -
Vaxcyte Inc 4Q 2024 - - - -
Biomx Inc 4Q 2024 - - up 83.57 % -
Peak Bio Inc 3Q 2024 - - up 317.44 % -
Pluri Inc 4Q 2024 up 242.59 % down -43.25 % - -
Protalix Biotherapeutics inc 4Q 2024 up 73.74 % up 1.44 % - up 100.68 %
Pharmacyte Biotech Inc 4Q 2024 - - - -
Prime Medicine Inc 4Q 2024 - up 944.5 % - -
Prokidney Corp 4Q 2024 - - - -
Poseida Therapeutics Inc 3Q 2024 up 667.19 % up 176.24 % - -
Mosaic Immunoengineering Inc 4Q 2024 - - - -
Qiagen N v 4Q 2024 up 0.98 % up 0.98 % down -75.51 % down -75.51 %
Quince Therapeutics Inc 4Q 2024 - - - -
Qrons Inc 4Q 2024 - - - -
Replimune Group Inc 4Q 2024 - - - -
Repligen Corp 4Q 2024 up 0.56 % up 8.18 % - -
Regenxbio Inc 4Q 2024 down-4.5 % down -12.33 % - -
Relay Therapeutics Inc 4Q 2024 - - - -
Revolution Medicines Inc 4Q 2024 - - - -
Redwoods Acquisition Corp 4Q 2024 - - - -
Recursion Pharmaceuticals Inc 4Q 2024 down-58.26 % down -82.57 % - -
Sab Biotherapeutics Inc 4Q 2024 down-62.4 % - - -
Sana Biotechnology Inc 4Q 2024 - - - -
Scilex Holding Company 4Q 2024 up 10.68 % up 3.21 % - -
Scinai Immunotherapeutics Ltd 4Q 2023 - - - -
Seagen Inc 3Q 2023 up 27.11 % up 7.42 % - -
Sangamo Therapeutics Inc 4Q 2024 up 269.78 % down -84.72 % - -
Solid Biosciences Inc 4Q 2024 - - - -
Silexion Therapeutics Corp 4Q 2024 - - - -
Senti Biosciences Inc 4Q 2024 - - - -
Sqz Biotechnologies Company 3Q 2023 - - - -
Sorrento Therapeutics Inc 2Q 2023 up 31.1 % down -7.54 % - -
Scholar Rock Holding Corp 4Q 2024 - - - -
Surrozen Inc 4Q 2024 - down -93.45 % - -
Sutro Biopharma Inc 4Q 2024 down-86.98 % up 73.81 % - -
Surface Oncology Inc 2Q 2023 - - - -
Springworks Therapeutics Inc 4Q 2024 up 3417.33 % - - -
Protara Therapeutics Inc 4Q 2024 - - - -
Tarsus Pharmaceuticals Inc 4Q 2024 up 407.86 % up 38.01 % - -
Tc Biopharm holdings Plc 1Q 2024 - - - -
Tracon Pharmaceuticals Inc 2Q 2024 down-99.39 % down -45 % - -
Tcr2 Therapeutics Inc 1Q 2023 - - - -
Tscan Therapeutics Inc 4Q 2024 down-90.78 % down -36.61 % - -
Bio techne Corp 4Q 2024 up 7.49 % up 2.72 % down -31.58 % up 3.84 %
Tectonic Therapeutic Inc 4Q 2024 - - - -
Instil Bio Inc 4Q 2024 - up 85.8 % - -
Tenaya Therapeutics Inc 4Q 2024 - - - -
Tourmaline Bio Inc 4Q 2024 - - - -
Turnstone Biologics Corp 4Q 2024 - - - -
Taysha Gene Therapies Inc 4Q 2024 down-43.9 % up 13.09 % - -
Titan Pharmaceuticals Inc 4Q 2024 - - - -
Tevogen Bio Holdings Inc 4Q 2024 - - - -
Twist Bioscience Corporation 4Q 2024 up 24.08 % up 4.73 % - -
Valneva Se 4Q 2023 down-57.46 % down -57.46 % - -
Vericel Corporation 4Q 2024 up 15.97 % up 30.17 % up 52.44 % -
10x Capital Venture Acquisition Corp Iii 3Q 2023 - - - -
Vigil Neuroscience Inc 4Q 2024 - - - -
Vir Biotechnology Inc 4Q 2024 down-26.29 % up 419.92 % - -
Vor Biopharma Inc 4Q 2024 - - - -
Vaxart Inc 4Q 2024 up 367.95 % up 207.82 % - -
Voyager Therapeutics Inc 4Q 2024 down-93.03 % down -74.51 % - -
Windtree Therapeutics Inc 4Q 2024 - - - -
X4 Pharmaceuticals Inc 4Q 2024 - up 156.07 % - -
Xtant Medical Holdings Inc 4Q 2024 up 14.95 % up 20.94 % - -
Zivo Bioscience Inc 3Q 2024 up 166.95 % - - -
Zura Bio Limited 4Q 2024 - - - -
Revenue
Biotechnology & Pharmaceuticals Industry

recorded in the 4. Quarter 2024 above average Revenue deterioration of -2.45 % year on year, Total Ranking #79 and ranking within sector #7.

Sequentially Revenues for Biotechnology & Pharmaceuticals Industry fell by -0.05 %.

More on Biotechnology & Pharmaceuticals Industry Revenue Growth




Income
Biotechnology & Pharmaceuticals Industry
in the 4. Quarter 2024 Net income contracted by -83.5 % year on year.

Sequentially, Biotechnology & Pharmaceuticals Industry Net income fell by -90.84 % sequentially.

More on Biotechnology & Pharmaceuticals Industry Income Growth




• Inc. Cont. Ops.
• Net Income
• EPS Cont. Ops.
• EPS Net
• Free Cash Flow
• Net Cash Flow
• Capex








Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com